Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6690373.pdf
Reference45 articles.
1. Bagwell, C. B., Mayo, S. W., Whetstone, S. D., Hitchcox, S. A., Baker, D. R., Herbert, D. J., Weaver, D. L., Jones, M. A. & Lovett, E. J. (1991). DNA histogram debris theory and compensation. Cytometry 12: 107–118.
2. Benraad, T. J., Geurts-Moespot, J., Grøndahl-Hansen, J., Schmitt, M., Heuvel, JJTM, deWitte, J. H., Foekens, J. A., Leake, R. E., Brünner, N. & Sweep, C. G. J. (1996). Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 workshop. Eur J Cancer 32A: 1371–1381.
3. Blankenstein, M. A. (1997). Biochemical assessment of tissue prognostic factors in breast cancer. Breast 6: 31–37.
4. Bouchet, C., Spyratos, F., Martin, P. M., Hacène, K., Gentile, A. & Oglobine, J. (1994). Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br J Cancer 69: 398–405.
5. Breiman, I., Friedman, J., Olshen, R. & Stone, C. (1984). Classification and Regression Trees. Chapman and Hall: New York
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endocrine-Disrupting Chemicals’ (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1;International Journal of Molecular Sciences;2020-12-03
2. Prognostic role of high cathepsin D expression in breast cancer: a systematic review and meta-analysis;Therapeutic Advances in Medical Oncology;2020-01
3. Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy;BMC Cancer;2019-01-15
4. DNA aneuploidy and breast cancer: a meta-analysis of 141,163 cases;Oncotarget;2016-08-09
5. Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model;PLOS ONE;2016-04-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3